New Diabetes Net
Copenhagen - A new Scandinavian Diabetes Network (SDN) has been established in co-operation between leading Scandina-vian experts in diabetes and metabolic disorders and Medicon A/S. The purpose of SDN is to establish a clinical network that can perform scientific research in pre-diabetes, diabetes, its micro- and macrovas-cular complications and other metabolic disorders. It also aims at performing phase I-IV trials for regulatory and other purposes and for evidence based medicine. Phase I or IIa studies with volunteers or patients from regional hospitals will be performed at the Medicon Clinical Pharmacology Unit. Later studies will be conducted at the clinical SDN sites in Denmark, Norway and Sweden. More than 250,000 type 2 diabetics are the research basis of this clinical network.